Shanghai Orsin Medical Technology Co., Ltd.
Focus on life and pursue excellence
Add to Cart
This is a next-generation blood collection system featuring high-activity silica clot activator and polymer separation gel. The clot activator accelerates coagulation within 5-8 minutes, reducing processing time by 60% versus conventional methods. The separation gel forms an inert barrier after centrifugation, cleanly partitioning serum/plasma from cellular components with hemolysis rates <0.1%. Compliant with ISO 6710 standards, it is optimized for clinical chemistry analyzers, immunoassay platforms, and mass spectrometry, delivering contamination-free samples for critical tests (e.g., glucose, lipids, hormones) to ensure diagnostic precision.
Rapid coagulation enables time-sensitive assays (e.g., cardiac troponin I, D-dimer) with TAT (turnaround time) reduced to ≤30 minutes.
Mass Screening Programs
Separation gel maintains sample integrity for 72 hours, supporting cold-chain logistics for epidemiological studies and high-volume health screenings.
Specialized Assays
Ultra-low residue design prevents interference in trace element analysis (e.g., lithium monitoring) and MS-based diagnostics.
Automated Laboratories
Enhanced tube mechanical strength validated for automated lines, minimizing probe clogging and optimizing workflow efficiency.